Respiratory Virus Vaccines Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030

Published on : Oct-2020 | List of Tables : 43 | List of Figures : 95 | No. of Pages : 170 | Report Code : FACT5199MR |

Global Respiratory Virus Vaccines Market Overview

At a time when acute respiratory illnesses are causing mayhem in society, respiratory virus vaccines have never been more sought-after. Fact MR, in its recent study, has analyzed the scope for expansion of the respiratory virus vaccines market, and has forecast it to rise at an above 7% CAGR from 2020 and 2030.

The threat posed by avian influenza to the global population is possibly at an all-time high in recent times. The tightening noose of COVID-19, coupled with the identification of numerous novel respiratory viruses, is underpinning the need for the development of therapeutic and preventive models. Inventing vaccines is potentially the most crucial step taken towards the prevention of widespread viral infections and the reduction of mortality associated with them. Against the backdrop of the ongoing pandemic, demand for respiratory virus vaccines is expected to surge exponentially. Fact MR expects the respiratory virus vaccines market size to surpass US$ 14 Bn valuation by the end of 2030.

Respiratory Virus Vaccines Market Insights by Type

Based on type, the respiratory virus vaccines market can be segmented into inactivated/ killed vaccines, live-attenuated vaccines, and recombinant vaccines. Among them, inactive/ killed vaccines currently account for a leading market share. The segment is forecast to remain strong, backed by a slew of launches in this category.

Adoption of robust research programs aimed at developing inactivated vaccine for COVID-19 will bode well for growth in the category as well as the overall market. Demand for vaccines has skyrocketed in the absence of a proper treatment for COVID-19. Governments and healthcare organizations from around the world are focusing on the discovery potential cure and ways to curb the pandemic. Driven by this, demand witnessed for inactive/ killed vaccines is unlikely to slow down over the coming years.

Respiratory Virus Vaccines Market Insights by Route of Administration

Based on route of administration, the market can be segmented into intramuscular, subcutaneous, and intranasal. Of these, the intramuscular segment is likely to remain dominant throughout the period of forecast.

Respiratory Virus Vaccines Market Insights by Indication

Based on indication, the global market can be classified into mumps & rubella, measles, influenza, coronavirus disease (COVID-19), and others. Of these, the influenza segment currently holds prominence. Rising cases of influenza around the world have made effective vaccination programs highly necessary for children. Over the coming years, the market will witness rising demand from the COVID-19 segment. In the absence of proper vaccination, governments around the world are leaving no stone unturned to discover a potential cure.

None of them are holding back from investing in research & development (R&D) towards finding a vaccine for the disease. Spurred by the impetus from various governments and healthcare organizations, this category has the potential of skyrocketing over the coming years.

Respiratory Virus Vaccines Market Insights by Age Group

On the basis of age group, the market can be bifurcated into adults and pediatrics. Of these, the pediatric segment held the maximum share in the market in 2019. However, demand from adults is rising steadily, and will continue scaling heights against the backdrop of the ongoing pandemic.

Respiratory Virus Vaccines Market Insights by End User

Among the end users, which include hospitals, clinics, physician offices, pharmacies, and stores, physician offices are likely to demonstrate considerably high demand for respiratory virus vaccines. Rising penetration of physician offices across remote locations will enable the segment to continue leading the market. Demand from hospitals too is expected to rise significantly over the course of the coming decade.

Regional Outlook of Respiratory Virus Vaccines Market

The global respiratory virus vaccines market is segmented into five key regions - North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Of these, North America accounts for a leading respiratory virus vaccines market share. Rising cases of influenza, coupled with demand for effective treatment and vaccination, is aiding expansion in this region. According to the Centers for Disease Control and Prevention (CDC), the U.S. witnesses nearly 20,000 deaths every year due to influenza. Considering this, demand for respiratory virus vaccines will remain high, as the U.S. and other countries within the region focus on embracing effective healthcare solutions.

Europe is forecast to emerge as the second-leading market for respiratory virus vaccines. Growth witnessed in the region is attributable to rising investments in R&D activities to develop a vaccine for COVID-19.

respiratory virus vaccines market competitive analysis

For a dashboard view of key players operating in the respiratory virus vaccines market, request a report sample

Respiratory Virus Vaccines Market: Key Players

Competition within the global respiratory virus vaccines market is surging in response to rising demand recorded around the world. To strengthen their footprints, manufacturers are likely to adopt inorganic strategies such as product development, mergers & acquisitions, and others.

Efforts towards research & development is expected to surge over the coming years, especially as market players are focusing on promising drug candidates in the pipeline. This will subsequently aid in the expansion of the market. Some of the leading players operating in the global respiratory virus vaccines market are Bharat Biotech, CSL Limited, AstraZeneca, Sanofi, GlaxoSmithKline plc, Merck & Co., Inc., Serum Institute of India Pvt. Ltd., and Sinovac Biotech Ltd.

The Analyst’s Viewpoint

“The unprecedented COVID-19 outbreak, coupled with the absence of a vaccine, has created immense scope for research & development within the respiratory virus vaccines market. While there are a few already in the pipeline, some market players are likely to enjoy greater sales proceeds once their vaccines are approved for selling commercially.”

COVID-19 Impact on Respiratory Virus Vaccines Market

The unprecedented outbreak of the novel coronavirus has had a significant impact on the respiratory virus vaccines market, compelling leading stakeholders to engage in research & development in war-like urgency. For instance, France-based Pasteur Institute has fuelled its R&D efforts to use modified vaccines for measles, to trick a patient’s body into producing antibodies capable of fighting against COVID-19 pathogens.

Besides this, market players are seen tapping into lucrative prospects across diverse segments. Since seasonal influenza causes thousands of hospitalizations in the U.S. each year, companies are tapping into growth prospects within this domain. With experts recommending greater investments in clinical trials to generate desired immune response, the respiratory virus vaccines market is poised to surge significantly over the coming years.

Respiratory Virus Vaccines Market: About the Report

Fact.MR has published an exclusive forecast report on the respiratory virus vaccines market for 2020 and 2030. The foremost objective of this report is to offer spearhead insights on the market scenario, demand generators, and technological advancements into the market. Also, the study addresses key dynamics that are expected to diversify the sales and future prospects of respiratory virus vaccines.              

The report on the respiratory virus vaccines market begins with an executive overview, in which, product definition has been provided. The report further proceeds with the taxonomy of the respiratory virus vaccines market, elaborating on key segments. Also, the report outlines visionary insights on the dynamics of the market, including the drivers, restraints, opportunities, trends, and pricing analysis, along with key factors favoring investments within the market.

Supply chain analysis and pricing analysis of the market, along with the difference between respiratory virus vaccines used as per application, have also been included in the report, to help readers clearly understand the product framework map in the market.

Respiratory Virus Vaccines Market - Scope of the Report

A recent study by Fact.MR on the respiratory virus vaccines market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial trends that are currently determining the growth of the respiratory virus vaccines market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of respiratory virus vaccines. The study also provides the dynamics that are responsible for influencing the future status of the respiratory virus vaccines market over the forecast period.

A detailed assessment of respiratory virus vaccines value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the respiratory virus vaccines market along with their product portfolios enhances the reliability of this comprehensive research study.

Respiratory Virus Vaccines Market: Report Summary

The study offers a comprehensive analysis on diverse features, including demand, product developments, revenue generation, and sales in the respiratory virus vaccines market across the globe.

A comprehensive estimate on the respiratory virus vaccines market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of respiratory virus vaccines during the forecast period. Price point comparison by region with global average price is also considered in the study.

Respiratory Virus Vaccines Market: Segmentation

Fact.MR has studied the respiratory virus vaccines market with detailed segmentation on the basis of type, route of administration, indication, age group, end user, and key regions.

Type

Route of Administration

Indication

Age Group

End User

Region

  • Inactivated/Killed Vaccines
  • Live-attenuated Vaccines
  • Recombinant Vaccines

 

  • Intramuscular
  • Intranasal
  • Subcutaneous

 

  • Influenza
  • Measles, Mumps & Rubella
  • Coronavirus Disease (COVID-19)
  • Others

 

  • Pediatric
  • Adults

 

 

  • Physician Offices
  • Hospitals
  • Clinics
  • Pharmacies/Stores

 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Respiratory Virus Vaccines Market: Analysis on Market Size Evaluation

The respiratory virus vaccines market has been analyzed for each market segment in terms of value (US$ Mn).

Market estimates at global and regional levels for respiratory virus vaccines are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent respiratory virus vaccines market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global respiratory virus vaccines market.

Respiratory Virus Vaccines Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the respiratory virus vaccines market report, which have helped deliver projections on regional markets. These chapters include regional macros (political economic and business environment outlook), which are expected to have a momentous influence on the growth of the respiratory virus vaccines market during the forecast period.

Country-specific valuation on demand for respiratory virus vaccines has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

Respiratory Virus Vaccines Market: In-depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of respiratory virus vaccines, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of respiratory virus vaccines has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status and predicting the competition level in the respiratory virus vaccines market. Prominent companies operating in the global respiratory virus vaccines market include CSL Limited, Sanofi, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Bharat Biotech, and Sinovac Biotech Ltd.

1. Executive Summary

    1.1. Summary of Key Findings

    1.2. Summary of Statistics 

    1.3. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Introduction

    2.2. Market Definition 

    2.3. Market Taxonomy

3. Market Risks & Trends Assessment

    3.1. COVID-19 Impact Benchmark with Previous Crisis  

        3.1.1. Change in Respiratory Virus Vaccines Demand and Consumption Growth

        3.1.2. Before and After COVID-19 Crisis (Projected)

        3.1.3. Before and after SARS Pandemic (Actual)

        3.1.4. Before and After Sub-prime Crisis – 2008 (Actual)

        3.1.5. Change in Demand post Recovery Period (After Each Crisis)

    3.2. Impact on Market Value (US$ Mn)

        3.2.1. Likely Loss of Value in 2020

        3.2.2. Mid-term and Long Term Forecast

        3.2.3. Quarter by Quarter Dip and Recovery Assessment 

    3.3. Anticipated Demand and Value Recovery Curve

        3.3.1. Likelihood of U-Shape Recovery

        3.3.2. Likelihood of L-Shape Recovery

    3.4. Recovery Period Assessment by Key Countries

4. Market Background and Associated Industry Indicators

    4.1. Global Pharmaceutical Industry Outlook

        4.1.1. Key Trends in Pharmaceutical Market

        4.1.2. Pharmaceutical Market, by Region

        4.1.3. Pharmaceutical Market, by Competition

    4.2. Global Healthcare Industry Outlook

        4.2.1. Key trends in Healthcare Industry

    4.3. Healthcare Industry, by Region

    4.4. Forecast Factors - Relevance & Impact for Respiratory Virus Vaccines

        4.4.1. Key Market Players Historic Growth

        4.4.2. Pharmaceutical Industry Growth Outlook

        4.4.3. Others

    4.5. Value Chain Analysis and Operating Margins 

        4.5.1. List of Raw Material Suppliers

        4.5.2. List of Key Manufacturers

        4.5.3. List of End-users

        4.5.4. Profit Margins 

        4.5.5. Notes on Value Added at Each Node in the Value Chain

    4.6. Market Dynamics

        4.6.1.  Drivers

        4.6.2. Restraints and Market Risks

        4.6.3. Opportunity Analysis

5. Global Respiratory Virus Vaccines Market Demand Analysis 2015-2019 and Forecast, 2020-2030

    5.1.  Historical Market   Analysis, 2015-2019

    5.2.  Current and Future Market   Projections, 2020-2030

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Respiratory Virus Vaccines Market - Pricing Analysis

    6.1. Regional Pricing Analysis 

    6.2. Pricing Break-up

    6.3. Global Average Pricing Analysis Benchmark

7. Global Respiratory Virus Vaccines Market Demand (in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) and Analysis by Type, 2015 - 2019

    8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by Type, 2020 - 2030

        8.3.1. Inactivated/Killed Vaccines

        8.3.2. Live-attenuated Vaccines

        8.3.3. Recombinant Vaccines

    8.4. Market Attractiveness Analysis by Type

9. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Analysis by Route of Administration, 2015 - 2019

    9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by Route of Administration, 2020 - 2030

        9.3.1. Intramuscular

        9.3.2. Intranasal

        9.3.3. Subcutaneous

10. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Analysis by Route of Administration, 2015 - 2019

    10.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by Indication, 2020 - 2030

        10.3.1. Influenza

        10.3.2. Measles, Mumps & Rubella

        10.3.3. Coronavirus Disease (COVID-19)

11. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group

    11.1. Global Respiratory Virus Vaccines Market Value Forecast, by Age Group, 2018–2030

        11.1.1. Pediatric 

        11.1.2. Adults

12. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group

13. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By End user

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) and Analysis by End-user, 2015 - 2019

    13.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by End-user, 2020 - 2030

        13.3.1. Physician’s Office

        13.3.2. Hospitals

        13.3.3. Clinics

        13.3.4. Pharmacies/Stores

14. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Region 

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) and  Analysis By Region, 2015 - 2019

    14.3. Current and Future Market Size (US$ Mn) and  Analysis and Forecast By Region, 2018 – 2028

        14.3.1. North America

        14.3.2. Latin America 

        14.3.3. Europe

        14.3.4. Asia Pacific

        14.3.5. Middle East & Africa 

15. North America Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    15.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        15.4.1. By Country

        15.4.2. U.S.

        15.4.3. Canada

        15.4.4. By Type 

        15.4.5. By Route of Administration

        15.4.6. By Indication

        15.4.7. By Age Group

        15.4.8. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Type 

        15.5.3. By Route of Administration

        15.5.4. By Indication

        15.5.5. By Age Group

        15.5.6. By End User

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. Latin America Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Trend Analysis by Market Taxonomy, 2015 - 2019

    16.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030

        16.4.1. By Country

        16.4.2. Brazil

        16.4.3. Mexico

        16.4.4. Rest of Latin America

        16.4.5. By Type 

        16.4.6. By Route of Administration

        16.4.7. By Indication

        16.4.8. By Age Group

        16.4.9. By End-user

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Type 

        16.5.3. By Route of Administration 

        16.5.4. By Indication

        16.5.5. By Age Group

        16.5.6. By End-user

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. Europe Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    17.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        17.4.1. By Country

        17.4.2. Germany

        17.4.3. Italy

        17.4.4. France

        17.4.5. U.K.

        17.4.6. Spain

        17.4.7. Russia

        17.4.8. Poland

        17.4.9. Rest of Europe

        17.4.10. By Type 

        17.4.11. By Route of Administration

        17.4.12. By Indication

        17.4.13. By Age Group

        17.4.14. By End-user

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Type 

        17.5.3. By Route of Administration

        17.5.4. By Indication

        17.5.5. By Age Group

        17.5.6. By End-user

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Asia Pacific Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    18.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        18.4.1. By Country

        18.4.2. China

        18.4.3. South Korea

        18.4.4. By Type 

        18.4.5. By Route of Administration

        18.4.6. By Indication

        18.4.7. By Age Group

        18.4.8. By End-user

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Type 

        18.5.3. By Route of Administration

        18.5.4. By Indication

        18.5.5. By Age Group

        18.5.6. By End-user

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    19.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        19.4.1. By Country

        19.4.2. GCC Countries

        19.4.3. Israel

        19.4.4. South Africa

        19.4.5. Rest of Middle East and Africa

        19.4.6. By Country

        19.4.7. By Type 

        19.4.8. By Route of Administration

        19.4.9. By Indication

        19.4.10. By Age Group

        19.4.11. By End-user

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Type 

        19.5.3. By Route of Administration

        19.5.4. By Indication

        19.5.5. By Age Group

        19.5.6. By End-user

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

20. Key Countries Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Respiratory Virus Vaccines Market Analysis

        20.2.1. Pricing Analysis

        20.2.2. Market Value Proportion Analysis by Market Taxonomy

        20.2.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.2.4. By Type 

        20.2.5. By Route of Administration

        20.2.6. By Indication

        20.2.7. By Age Group

        20.2.8. By End-user

    20.3. Canada Respiratory Virus Vaccines Market Analysis

        20.3.1. Pricing Analysis

        20.3.2. Market Value Proportion Analysis by Market Taxonomy

        20.3.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.3.4. By Type 

        20.3.5. By Route of Administration

        20.3.6. By Indication

        20.3.7. By Age Group

        20.3.8. By End-user

    20.4. Germany Respiratory Virus Vaccines Market Analysis

        20.4.1. Pricing Analysis

        20.4.2. Market Value Proportion Analysis by Market Taxonomy

        20.4.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.4.4. By Type 

        20.4.5. By Route of Administration

        20.4.6. By Indication

        20.4.7. By Age Group

        20.4.8. By End-user

    20.5. France Respiratory Virus Vaccines Market Analysis

        20.5.1. Pricing Analysis

        20.5.2. Market Value Proportion Analysis by Market Taxonomy

        20.5.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.5.4. By Type 

        20.5.5. By Route of Administration

        20.5.6. By Indication

        20.5.7. By Age Group

        20.5.8. By End-user

    20.6. UK Respiratory Virus Vaccines Market Analysis

        20.6.1. Pricing Analysis

        20.6.2. Market Value Proportion Analysis by Market Taxonomy

        20.6.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.4. By Type 

        20.6.5. By Route of Administration

        20.6.6. By Indication

        20.6.7. By Age Group

        20.6.8. By End-user

        20.6.9. BENELUX Respiratory Virus Vaccines Market Analysis

        20.6.10. Pricing Analysis

        20.6.11. Market Value Proportion Analysis by Market Taxonomy

        20.6.12. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.13. By Type 

        20.6.14. By Route of Administration

        20.6.15. By Indication

        20.6.16. By Age Group

        20.6.17. By End-user

        20.6.18. Russia Respiratory Virus Vaccines Market Analysis

        20.6.19. Pricing Analysis

        20.6.20. Market Value Proportion Analysis by Market Taxonomy

        20.6.21. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.22. By Type 

        20.6.23. By Route of Administration

        20.6.24. By Indication

        20.6.25. By Age Group

        20.6.26. By End-user

        20.6.27. India Respiratory Virus Vaccines Market Analysis

        20.6.28. Pricing Analysis

        20.6.29. Market Value Proportion Analysis by Market Taxonomy

        20.6.30. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.31. By Type 

        20.6.32. By Route of Administration

        20.6.33. By Indication

        20.6.34. By Age Group

        20.6.35. By End-user

        20.6.36. Malaysia Respiratory Virus Vaccines Market Analysis

        20.6.37. Pricing Analysis

        20.6.38. Market Value Proportion Analysis by Market Taxonomy

        20.6.39. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.40. By Type 

        20.6.41. By Route of Administration

        20.6.42. By Indication

        20.6.43. By Age Group

        20.6.44. By End-user

        20.6.45. China Respiratory Virus Vaccines Market Analysis

        20.6.46. Pricing Analysis

        20.6.47. Market Value Proportion Analysis by Market Taxonomy

        20.6.48. Market Value (US$ Mn) and Analysis and Forecast by Market Taxonomy

        20.6.49. By Type 

        20.6.50. By Route of Administration

        20.6.51. By Indication

        20.6.52. By Age Group

        20.6.53. By End-user

        20.6.54. Poland Respiratory Virus Vaccines Market Analysis

        20.6.55. Pricing Analysis

        20.6.56. Market Value Proportion Analysis by Market Taxonomy

        20.6.57. Market Value (US$ Mn) and Analysis and Forecast by Market Taxonomy

        20.6.58. By Type 

        20.6.59. By Route of Administration

        20.6.60. By Indication

        20.6.61. By Age Group

        20.6.62. By End-user

        20.6.63. South Korea Respiratory Virus Vaccines Market Analysis

        20.6.64. Pricing Analysis

        20.6.65. Market Value Proportion Analysis by Market Taxonomy

        20.6.66. Market Value (US$ Mn) and Analysis and Forecast by Market Taxonomy

        20.6.67. By Type 

        20.6.68. By Route of Administration

        20.6.69. By Indication

        20.6.70. By Age Group

        20.6.71. By End-user

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies (Respiratory Virus Vaccines)

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. CSL Limited

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.2. Sanofi

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

        22.3.3. AstraZeneca

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

        22.3.4. Merck & Co., Inc.

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

        22.3.5. GlaxoSmithKline plc

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

        22.3.6. Serum Institute of India Pvt. Ltd.

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

        22.3.7. Bharat Biotech

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

        22.3.8. Sinovac Biotech Ltd.

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Respiratory Virus Vaccines Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030